Short Interest in NewGenIvf Group Limited (NASDAQ:NIVF) Rises By 311.9%

NewGenIvf Group Limited (NASDAQ:NIVF) was the target of a large growth in short interest in the month of May. As of May 15th, there was short interest totaling 64,064 shares, a growth of 311.9% from the April 30th total of 15,554 shares. Currently, 38.1% of the shares of the stock are sold short. Based on an average trading volume of 2,648,206 shares, the short-interest ratio is currently 0.0 days.

Insiders Place Their Bets

In related news, major shareholder Financial Lp Hrt sold 85,317 shares of the company’s stock in a transaction that occurred on Wednesday, May 27th. The shares were sold at an average price of $0.80, for a total transaction of $68,253.60. Following the sale, the insider owned 54,561 shares of the company’s stock, valued at approximately $43,648.80. This represents a 60.99% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Company insiders own 31.80% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reissued a “sell (d)” rating on shares of NewGenIvf Group in a report on Monday, April 27th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock presently has a consensus rating of “Sell”.

NewGenIvf Group Trading Up 21.2%

Shares of NASDAQ:NIVF opened at $1.03 on Friday. The company’s fifty day moving average price is $1.66 and its 200-day moving average price is $6.74. NewGenIvf Group has a one year low of $0.72 and a one year high of $1,839.00. The company has a debt-to-equity ratio of 0.16, a current ratio of 3.12 and a quick ratio of 2.98.

NewGenIvf Group (NASDAQ:NIVF) last issued its quarterly earnings results on Tuesday, March 31st. The company reported ($287.24) EPS for the quarter. The firm had revenue of $1.42 million for the quarter. As a group, analysts anticipate that NewGenIvf Group will post 4.74 EPS for the current year.

About NewGenIvf Group

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.